Lauren Welch, Kammi Fox-Kay, and Cathy Simmons discuss their approaches to educating patients on the importance of waiting for biomarker testing before starting therapy for non–small cell lung cancer (NSCLC) to individualize therapy with the treatment that is best suited for their cancer and to achieve the best outcomes.
Educating Patients About the Need to Wait for Biomarker Test Results
Thoracic Oncology Nurse Navigator
Community Healthcare System
Munster, Indiana
Community Healthcare System
Munster, Indiana
Thoracic Oncology Navigator
Sarah Cannon Cancer Institute
Plano, Texas
Sarah Cannon Cancer Institute
Plano, Texas
Nurse Practitioner
Tennessee Oncology
Nashville, TN
Tennessee Oncology
Nashville, TN
Get TOP in Your Inbox
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our e-newsletter!